Evidence map›Paper›PMID 36902074›Full record

ReviewInternational journal of molecular sciences2023

The Effects of

Erika Richter, Thangiah Geetha, Donna Burnett, Tom L Broderick, Jeganathan Ramesh Babu

Open access · goldFull text readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 66 citations in OpenAlex.

  1. Antioxidants (Basel, Switzerland) · 2026
    Review
  2. Antioxidants (Basel, Switzerland) · 2026
    Article
  3. The Biochemical Role of Bitter Melon (Food science & nutrition · 2026
    Article
  4. Observational
  5. Bioactive Compounds ofInternational journal of molecular sciences · 2026
    Article
  6. Article
  7. Article
  8. Pharmacological activities ofFrontiers in pharmacology · 2026
    Article
  9. Review
  10. Profiling and cheminformatics bioprospection of curcurbitacin I and momordin Ic fromJournal of enzyme inhibition and medicinal chemistry · 2025
    Article
  11. Plants (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Exploring the therapeutic potential ofIn silico pharmacology · 2025
    Article
  17. Article
  18. Review
  19. Exploring beetroot (RSC advances · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Erika RichterDepartment of Nutritional Sciences, Auburn University, Auburn, AL 36849, USA.ORCID 0009-0009-5867-5231
Thangiah GeethaDepartment of Nutritional Sciences, Auburn University, Auburn, AL 36849, USA.ORCID 0000-0001-6358-0012
Donna BurnettDepartment of Nutritional Sciences, Auburn University, Auburn, AL 36849, USA.
Tom L BroderickDepartment of Physiology, Laboratory of Diabetes and Exercise Metabolism, College of Graduate Studies, Midwestern University, Glendale, AZ 85308, USA.
Jeganathan Ramesh BabuDepartment of Nutritional Sciences, Auburn University, Auburn, AL 36849, USA.
Auburn University · USMidwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T2DM is a complex metabolic disorder characterized by hyperglycemia and glucose intolerance. It is recognized as one of the most common metabolic disorders and its prevalence continues to raise major concerns in healthcare globally. Alzheimer's disease (AD) is a gradual neurodegenerative brain disorder characterized by the chronic loss of cognitive and behavioral function. Recent research suggests a link between the two diseases. Considering the shared characteristics of both diseases, common therapeutic and preventive agents are effective. Certain bioactive compounds such as polyphenols, vitamins, and minerals found in vegetables and fruits can have antioxidant and anti-inflammatory effects that allow for preventative or potential treatment options for T2DM and AD. Recently, it has been estimated that up to one-third of patients with diabetes use some form of complementary and alternative medicine. Increasing evidence from cell or animal models suggests that bioactive compounds may have a direct effect on reducing hyperglycemia, amplifying insulin secretion, and blocking the formation of amyloid plaques. One plant that has received substantial recognition for its numerous bioactive properties is

Indexed as

Alzheimer DiseaseDiabetes Mellitus, Type 2HyperglycemiaMomordica charantiaPlant ExtractsAnimalsHypoglycemic AgentsHypoglycemic AgentsPlant ExtractsAlzheimer’s diseasebioactivebitter melon (M. charantia)glucose-lowering effectshypoglycemicmedicinal plantsnaturalneuroprotectiveprevalencetherapeutictype 2 diabetes mellitus

Identifiers

PMID36902074
PMCPMC10002567
OpenAlexW4322629752

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read9
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.